Roche

Age-Related Macular Degeneration: A Promising Investment Opportunity
Seeking Alpha
Tue, 01/22/13 - 10:43 am
age-related macular degeneration
Lpath
Merck
Pfizer
Bristol-Myers Squibb
Roche
ShangPharma
FDA fast tracks two new lung cancer drugs
PM Live
Fri, 01/18/13 - 10:17 am
fast track
FDA
Boehringer Ingelheim
Astellas
Roche
Afatinib
Tarceva
non-small cell lung cancer
Shifts in Roche's Top Brass
Yahoo/Zacks.com
Fri, 01/18/13 - 09:19 am
Roche
Genentech takes Exelixis drug into Phase III melanoma trial
Bizjournals.com
Thu, 01/17/13 - 10:19 am
Exelixis
Genentech
melanoma
Roche
Zelboraf
GDC-0973
Analysis: Drug industry bets on new blockbusters in 2013
Reuters
Tue, 01/15/13 - 11:37 am
Roche
GlaxoSmithKline
Eli Lilly
Biogen Idec
Gilead Sciences
Novo Nordisk
Roche And AstraZeneca Overhaul R&D Operations
Pharmalot
Tue, 01/15/13 - 11:35 am
Roche
AstraZeneca
R&D
Drugmakers report U.S. shortages of flu vaccine, Tamiflu
Reuters
Thu, 01/10/13 - 11:25 am
drug shortages
Flu
Tamiflu
Roche
Sanofi
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wed, 01/9/13 - 12:20 pm
FDA
drug approvals
Roche
T-DM1
Aveo
Delcath
Navidea Biopharmaceuticals
Lymphoseek
tivozanib
chemostat
Roche chairman says Illumina bid off the table: paper
Yahoo/Reuters
Mon, 01/7/13 - 10:36 am
Roche
M&A
Illumina
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
And the Obesity Plot Thickens
Motley Fool
Wed, 01/2/13 - 11:58 am
obesity
Vivus
Arena Pharmaceuticals
Roche
Orexigen
mimAb1
Amgen
Zafgen
Belviq
Qsymia
beloranib
Contrave
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Rytary
GSK
Impax Labs
Celgene
pomalidomide
Roche
T-DM1
Immunogen
Eliquis
Pfizer
Bristol-Myers Squibb
Biogen Idec
BG-12
4 FDA Approvals in 1 Day
Motley Fool
Wed, 12/26/12 - 09:30 am
FDA
drug approvals
Roche
Tamiflu
Gilead Sciences
Gattex
NPS Pharmaceuticals
Alexza
Adasuve
VariZIG
Cangene
Roche Might Buy Illumina, Echo Therapeutics Prices Public Offering: Healthcare Business Wrap
Wall Street Cheat Street
Sat, 12/22/12 - 01:04 pm
Roche
Illumina
Echo Therapeutics
M&A
Roche Favors Deals Up to $7 Billion Over Buybacks, CFO Says
Bloomberg
Thu, 12/20/12 - 11:17 am
Roche
M&A
Illumina Shares Gain on Report of Higher Roche Bid
Bloomberg
Thu, 12/20/12 - 11:13 am
Roche
Illumina
M&A
Roche looks to earn even more from Perjeta with EU nod
Fierce Pharma
Fri, 12/14/12 - 12:32 pm
Roche
Perjeta
Europe
breast cancer
Avastin Shows No Benefit for Earlier Colon Cancer: Study
Medine Plus
Thu, 12/13/12 - 11:52 am
Avastin
colon cancer
Roche
Looking For A Long-Term Pharma Play?
Seeking Alpha
Sun, 12/9/12 - 11:31 am
Roche
Astrazena
Bristol-Myers Squibb
GSK
5 Drug Hopefuls That Are Going to Change Your Life: Part 3
Motley Fool
Sun, 12/9/12 - 11:29 am
Actonel
Reclast
Boniva
Warner Chilcott
Amgen
Prolia
Odanacatib
Merck
Novartis
GSK
Roche

Pages